Through a nonprofit company named Civica Rx, a group of large hospitals in the U.S.plan to make and sell generic versions of insulin in 2024. Civica Rx’s prices should be only a fraction of today’s list prices for insulin that can range from $125 to $500. High insulin prices have greatly affect Black people who, according to the American Diabetes Association, are 60% more likely to be diagnosed with diabetes.
Source: https://www.washingtonpost.com/business/2022/03/03/cheaper-insulin-plan/